You can view the latest news of the Company.
 
Select Another Company
 
Market Cap. (Rs.) 93716.89 Cr. P/BV 5.99 Book Value (Rs.) 342.46
52 Week High/Low (Rs.) 2403/1795 FV/ML 2/1 P/E(X) 28.56
Bookclosure 25/07/2025 EPS (Rs.) 71.85 Div Yield (%) 0.58
Date and TimeHeadlines
16/09/2025 21:25 Lupin Ltd. - U.S. FDA Has Conducted An Inspection Of Company'S Inje...
13/09/2025 12:12 Lupin Ltd. - General Updates
11/09/2025 12:12 Lupin Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates
11/09/2025 12:09 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Inve...
06/09/2025 09:08 Lupin Ltd. - Updates
06/09/2025 09:05 Lupin Ltd. - U.S. FDA Has Conducted A Product-Specific Pre-Approval...
03/09/2025 16:05 Lupin Ltd. - Copy of Newspaper Publication
03/09/2025 15:11 Lupin bags USFDA nod for Generic Schizophrenia, Bipolar Disorder Drug
03/09/2025 13:04 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release ...
03/09/2025 13:03 Lupin Ltd. - Press Release
29/08/2025 11:12 Lupin Ltd. - General Updates
29/08/2025 11:09 Lupin Ltd. - ESG Rating By Crisil ESG Ratings & Analytics Ltd.
27/08/2025 13:48 Lupin Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates
27/08/2025 13:36 Lupin Ltd. - Copy of Newspaper Publication
26/08/2025 15:36 Lupin Ltd. - Shareholder Meeting / Postal Ballot-Notice of Postal B...
26/08/2025 15:34 Lupin Ltd. - Shareholders meeting
21/08/2025 12:53 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Allotment of E...
21/08/2025 12:51 Lupin Ltd. - ESOP/ESOS/ESPS
20/08/2025 18:28 Lupin Ltd. - Change in Director(s)
20/08/2025 18:20 Lupin Ltd. - Announcement under Regulation 30 (LODR)-Change in Dire...
12